Quantcast

Latest Escitalopram Stories

2009-10-02 08:05:00

DETROIT, Oct. 2 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that, as part of the previously announced settlement of the legal proceedings related to Lexapro® (escitalopram oxalate) tablets, it closed an Asset Purchase Agreement ("APA") transaction with Forest Laboratories, Inc. ("Forest") to acquire several products from Forest's Inwood line of business. The ANDA patent litigation settlement resolves litigation involving...

783b86bf53d4c3b01c465879d992207f1
2009-09-11 08:03:24

Brain-wave patterns may predict how effective medication will be It is a long, slow slog to treat major depression. Many antidepressant medications are available, but no single biomarker or diagnostic test exists to predict which one is right for an individual. As a result, for more than half of all patients, the first drug prescribed doesn't work, and it can take months to figure out what does. Now, based on the final results of a nationwide study led by UCLA, clinicians may be able to...

2009-08-17 07:00:00

WALTHAM, Mass., Aug. 17 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although generic erosion will negatively impact the major depression drug market in the United States, patent protection of key blockbuster agents will help drive market growth in Europe and Japan through 2018. The new Pharmacor report entitled Major Depressive Disorder finds that sales of therapies for major depression in...

9cd0ec926c17c31fbd62d0664ec854be1
2009-08-12 11:20:00

Researchers from the U.S. Food and Drug Administration released an analysis on Tuesday that showed people under age 25 who take antidepressants have a higher risk of suicide, but adults older than that do not, Reuters reported. The new data supports the agency's age-related warnings on the drugs' labeling. Clinical trials from 2003 showed the use of antidepressant drugs increased the risk of suicidal thoughts and behaviors in those under age 18, leading regulators from the U.S. and Europe to...

2009-07-10 08:15:00

NEW YORK, July 10, 2009 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX) and its wholly-owned subsidiary, Forest Laboratories Holdings, Ltd. (collectively, "Forest"), and H. Lundbeck A/S ("Lundbeck") announced today that they have entered into a settlement agreement with Sun Pharmaceutical Industries Ltd. ("Sun Pharma", a reference that includes its 100% subsidiaries) and Caraco Pharmaceutical Laboratories, Ltd. ("Caraco"), regarding pending patent infringement disputes...

2009-07-10 08:15:00

DETROIT, July 10 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (NYSE Amex: CPD) announced that, as part of the settlement of the legal proceedings related to Lexapro(R) (escitalopram oxalate) tablets, it entered into an Asset Purchase Agreement with Forest Laboratories, Inc. ("Forest") to acquire several products from Forest's Inwood line of business. The ANDA patent litigation settlement resolves litigation involving Caraco, Forest, Forest Holdings, Ltd., and H. Lundbeck...

2009-06-02 08:11:28

 A new multi-center study, conducted at The Feinstein Institute for Medical Research in collaboration with five other centers throughout the country, tested the commonly prescribed antidepressant citalopram and found that it was no more effective than placebo in altering obsessive features of the condition "“ the spinning, rocking and repetitive behavior.Like everything in medicine, the use of antidepressants in children with autism spectrum disorder took off before there was...

2009-05-12 07:00:00

Use of Atypicals In Major Depression Treatment Is Growing, According to a New Report from Decision Resources Patient-Flow Forecasts Between Pristiq and Effexor XR Need to Take Into Account Reimbursement Hurdles WALTHAM, Mass., May 12 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Forest Laboratories' Lexapro is no longer the leading first-line agent of choice for the treatment of major...

6c68f4c4ccd7899ca0cd34560cdb7cbf1
2009-04-30 07:05:00

Preliminary results of a new study suggest that pregnant women who are also substance-dependent and smoke cigarettes may significantly benefit from certain antidepressant drugs. In particular, researchers noted that the antidepressant bupropion "“ commonly known by the brand name Wellbutrin "“ helped women to curb their smoking habits. "We are encouraged by the findings given that both depression and smoking are highly prevalent in pregnant, substance-dependent patients and are...

2009-04-21 07:00:00

Company Provides Fiscal Year 2010 EPS Guidance in the Range of $3.45-$3.55 Per Share NEW YORK, April 21 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE: FRX), a U.S.-based pharmaceutical company, today announced that earnings per share for the fourth quarter of fiscal year 2009 were $0.31 per share. Excluding the one-time USAO charge described below, non-GAAP earnings per share for the fourth fiscal quarter equaled $0.76. This compares to last year's reported earnings per share...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related